2 Years After Germany's Regulation For Digital Health Apps, What Can We Learn?
At the end of 2019, the Digital Healthcare Act (Digitales Versorgungsgesetz, DVG) introduced a dedicated pathway enabling reimbursement of digital health...
“Digital Health” continues to evolve quickly, with technological innovations providing new opportunities for patients, providers, and payers. Despite the clear opportunity to improve health through digitally-enabled interventions, it remains challenging to achieve commercial success for digital products. Key challenges include securing favorable market access and reimbursement, incorporating digital tools into provider workflows, and optimizing the patient experience.
Informed by decades of experience developing go-to-market strategies for health technologies (pharma, biotech, MedTech, DTx, etc.), our team brings deep expertise in value demonstration, access and reimbursement, pricing, demand generation, and business model development to overcome the uptake and payment hurdles facing emerging digital technologies.
Our focus areas
Engagements
- 01Market access strategy for a device/App combination in diabetesCRA approach Conducted a thorough market access landscape analysis in six countries covering reimbursement, pricing, purchasing, access pathways, and evidence...View engagement
- 02Five-year vision in prescription digital therapeuticsCRA approach Facilitated a two-day strategic workshop with client’s leadership team to debate and align on “what company should be” vs. “what company should...View engagement
- 03Value proposition reimbursement pathways for a DTxCRA approach Evaluated relevant eHealth analogues to establish the likely reimbursement and funding pathways for a novel eHealth product. Determined PMA...View engagement